-- Light & Wonder（ASX:LNW）は木曜日、第1四半期の調整後1株当たり利益が1.45ドルとなり、前年同期の1.35ドルから増加したと発表した。
ファクトセットが調査したアナリストは、1.45ドルの利益を予想していた。
3月31日までの3ヶ月間の売上高は7億9,000万ドルで、前年同期の7億7,400万ドルから減少した。ファクトセットが調査したアナリストは、8億3,150万ドルを予想していた。
同社は、長期戦略を着実に実行し、2028年の財務目標達成に向けて前進する中で、2026年の連結調整後EBITDA（金利・税金・減価償却費控除前利益）の成長率を中～高一桁台と見込んでいる。
Saudi Arabia's business confidence index stood at 54.5 points in April, up from 52.1 points in March, data from the General Authority for Statistics showed Thursday.The monthly change in confidence was 4.6% higher, compared with a 14.2% decrease earlier.The statistics agency noted that the reading reflected sustained optimism in the business sector, underpinned by expectations of continued growth in various segments and confidence in the stability of economic activity.
Germany's monthly factory orders gained 5% in March, following a revised 1.4% increase in February, according to preliminary data from the country's Federal Statistical Office published Thursday.Analysts expected a 1% rise for the month.On a yearly basis, new orders in manufacturing were up 6.3%, against the 3.5% jump earlier.
Jointown Pharmaceutical (SHA:600998) unit Beijing Jingfeng Pharmaceutical Shandong passed a good manufacturing practices (GMP) compliance inspection by the Shandong Medical Products Administration for its tablet production lines.The inspection covered Workshop 801, which produces metformin hydrochloride enteric-coated tablets for type 2 diabetes and isosorbide dinitrate tablets for coronary heart disease and angina, according to a Thursday filing with the Shanghai bourse.Shares of the pharmaceutical company were down 1% in recent trade.